Suzanne S. Farid

发表

Innovation in biopharmaceutical manufacture

Andrew Davidson, Suzanne S. Farid, 2014 .

A tool to predict the economic benefit of alternative technologies for allogeneic cell therapy manufacture at commercial scale

Suzanne S. Farid, Ana S. Simaria, Sally Hassan, 2013 .

A mixed-integer nonlinear programming model for antibody purification processes

Suzanne S. Farid, Ana S. Simaria, Songsong Liu, 2012 .

Optimising chromatography strategies of antibody purification processes by mixed integer fractional programming techniques

Lazaros G. Papageorgiou, Suzanne S. Farid, Ana S. Simaria, 2014, Comput. Chem. Eng..

Multi-objective biopharma capacity planning under uncertainty using a flexible genetic algorithm approach

Suzanne S. Farid, Karolis Jankauskas, S. Farid, 2019, Comput. Chem. Eng..

Cost-Effective Manufacturing Strategies For Feasible Commercialisation Of Autologous Car T-Cell Products

Suzanne S. Farid, Tania Pereira Chilima, Thierry Bovy, 2017 .

A multi-level meta-heuristic algorithm for the optimisation of antibody purification processes

Suzanne S. Farid, Ana S. Simaria, Richard Turner, 2012 .

Fast genetic algorithm approaches to solving discrete-time mixed integer linear programming problems of capacity planning and scheduling of biopharmaceutical manufacture

Lazaros G. Papageorgiou, Suzanne S. Farid, Karolis Jankauskas, 2019, Comput. Chem. Eng..

How implementation of Quality by Design and advances in Biochemical Engineering are enabling efficient bioprocess development and manufacture

Suzanne S. Farid, Sunil Chhatre, Paul Bird, 2011 .

Stochastic multi-objective optimization for the design of drug portfolio development strategies

Suzanne S. Farid, Nigel J. Titchener-Hooker, Edmund D. George, 2007 .

Modelling of the biopharmaceutical drug development pathway and portfolio management

Suzanne S. Farid, Anuradha Rajapakse, Nigel John Titchener-Hooker, 2005, Comput. Chem. Eng..

Decision-support tool for risk analysis in biopharmaceutical manufacture

Suzanne S. Farid, Nigel J. Titchener-Hooker, John Washbrook, 2001 .

Efficient Discovery of Chromatography Equipment Sizing Strategies for Antibody Purification Processes Using Evolutionary Computing

Suzanne S. Farid, Ana S. Simaria, Richard Allmendinger, 2012, PPSN.

Modern day monitoring and control challenges outlined on an industrial-scale benchmark fermentation process

Suzanne S. Farid, Barry Lennox, David Lovett, 2019, Comput. Chem. Eng..

Computer-Aided Design and Evaluation of Batch and Continuous Multi-Mode Biopharmaceutical Manufacturing Processes

Suzanne S. Farid, Sa V. Ho, James Pollock, 2012 .

Mathematical programming approaches for downstream processing optimisation of biopharmaceuticals

Lazaros G. Papageorgiou, Suzanne S. Farid, Ana S. Simaria, 2015 .

Evaluating the economic and operational feasibility of continuous processes for monoclonal antibodies

Suzanne S. Farid, Sa V. Ho, James Pollock, 2014 .

The use of a modelling tool to quantify risks and uncertainty in the biomanufacturing industry

Suzanne S. Farid, Nigel J. Titchener-Hooker, John Washbrook, 2003 .

Modelling biopharmaceutical manufacture: Design and implementation of SimBiopharma

Suzanne S. Farid, John Washbrook, Nigel John Titchener-Hooker, 2007, Comput. Chem. Eng..

Novel software tools for evaluating integration within a downstream process - A case study of expanded bed adsorption vs packed bed adsorption.

Suzanne S. Farid, Nigel J. Titchener-Hooker, John Washbrook, 2003 .

Retrofit Decisions within the Biopharmaceutical Industry: An EBA Case Study

Suzanne S. Farid, Nigel J. Titchener-Hooker, John Washbrook, 2006 .

Impact of allogeneic stem cell manufacturing decisions on cost of goods, process robustness and reimbursement

Suzanne S. Farid, Fabien Moncaubeig, Tania Pereira Chilima, 2018, Biochemical Engineering Journal.

Estimating capital investment and facility footprint in cell therapy facilities

Suzanne S. Farid, Tania Pereira Chilima, Fabien Moncaubeig, 2020 .

Production planning of batch and semi-continuous bioprocesses across multiple biopharmaceutical facilities

Lazaros G. Papageorgiou, Suzanne S. Farid, Thomas Daszkowski, 2012 .

A hierarchical framework for modelling biopharmaceutical manufacture to address process and business needs

Suzanne S. Farid, Nigel J. Titchener-Hooker, John Washbrook, 2000 .

A multi-level metaheuristic algorithm to optimise antibody purification processes at the bioprocess-business interface.

Suzanne S. Farid, Ana S. Simaria, Richard Turner, 2012 .

Integrated approach to improving the value potential of biopharmaceutical R&D portfolios while mitigating risk

Suzanne S. Farid, Nigel J. Titchener-Hooker, Anuradha Rajapakse, 2006 .

Optimising the production of next generation biopharmaceuticals through dynamic process simulation

Suzanne S. Farid, Adam Stonier, Nicholas Hutchinson, 2009 .

Process Economic Drivers in Industrial Monoclonal Antibody Manufacture

Suzanne S. Farid, S. Farid, 2008 .

Prediction of biopharmaceutical facility fit issues using decision tree analysis

Nina F. Thornhill, Suzanne S. Farid, Yang Yang, 2013 .

Economic and operational appraisal of an allogeneic CAR T-cell bioprocess

Suzanne S. Farid, Michael J. Jenkins, Mark W Leonard, 2017 .

Application of multivariate data analysis in the monitoring and control of mammalian cell processes

Suzanne S. Farid, Rahul Pradhan, Stephen Goldrick, 2016 .

An Optimisation-based Approach for Biopharmaceutical Manufacturing

Lazaros G. Papageorgiou, Suzanne S. Farid, Ana S. Simaria, 2014 .

Integration of stochastic simulation with advanced multivariate and visualisation analyses for rapid prediction of facility fit issues in biopharmaceutical processes

Nina F. Thornhill, Suzanne S. Farid, Adam Stonier, 2011 .

Toward Greener Therapeutic Proteins

Suzanne S. Farid, Sa V. Ho, James Pollock, 2011 .

Stem cell bioprocessing for drug discovery - process economics and optimisation

Suzanne S. Farid, S Simaria, Sa V. Ho, 2013 .

Multivariate data analysis enabling improved clone selection

Suzanne S. Farid, Rahul Pradhan, Stephen Goldrick, 2018 .

A multi-criteria decision-making framework for the selection of strategies for acquiring biopharmaceutical manufacturing capacity

Suzanne S. Farid, Edmund George, Nigel John Titchener-Hooker, 2007, Comput. Chem. Eng..

Patient-specific hiPSC bioprocessing for drug screening: Bioprocess economics and optimisation

Suzanne S. Farid, Sa V. Ho, Michael J. Jenkins, 2016 .

Continuous-Time Heuristic Model for Medium-Term Capacity Planning of a Multi-Suite, Multi-Product Biopharmaceutical Facility

Lazaros G. Papageorgiou, Suzanne S. Farid, Karolis Jankauskas, 2017 .

A new lot sizing and scheduling heuristic for multi-site biopharmaceutical production

Suzanne S. Farid, Jürgen Branke, Richard Allmendinger, 2017, J. Heuristics.

Medium term planning of biopharmaceutical manufacture under uncertainty

Lazaros G. Papageorgiou, Suzanne S. Farid, Nigel J. Titchener-Hooker, 2006 .

Industry 4.0 : a vision for personalized medicine supply chains?

Suzanne S. Farid, Nilay Shah, Juergen Branke, 2016 .

Time-series datamining for continuous bioprocess analysis

Suzanne S. Farid, Yang Yang, 2017 .

Mixed integer optimisation of antibody purification processes

Lazaros G. Papageorgiou, Suzanne S. Farid, Ana S. Simaria, 2013 .

Lentiviral vector bioprocess economics for cell and gene therapy commercialization

Suzanne S. Farid, Bo Kara, Ruxandra-Maria Comisel, 2020 .

An evaluation of the cGMP manufacturing process economics and high-throughput characterization of targeted secretion inhibitors

Suzanne S. Farid, Paul A. Dalby, Andrew Splevins, 2016 .

Cost-effective bioprocess design for the manufacture of allogeneic CAR-T cell therapies using a decisional tool with multi-attribute decision-making analysis

Suzanne S. Farid, Michael J. Jenkins, S. Farid, 2018, Biochemical Engineering Journal.

Integrated economic and experimental framework for screening of primary recovery technologies for high cell density CHO cultures

Suzanne S. Farid, Adam Stonier, Nigel J. Titchener‐Hooker, 2016, Biotechnology journal.

Determining the commercial feasibility of autologous CAR T-cell products

Suzanne S. Farid, Thierry Bovy, Fabien Moncaubeig, 2016 .

Tuning Evolutionary Multiobjective Optimization for Closed-Loop Estimation of Chromatographic Operating Conditions

Suzanne S. Farid, Richard Allmendinger, Nigel John Titchener-Hooker, 2014, PPSN.

Considering disposables for the manufacture of early phase biopharmaceutical candidates

Suzanne S. Farid, Nigel J. Titchener-Hooker, 2005 .

Framework for assessing the robustness of optimal antibody purification configurations to titre variances

Suzanne S. Farid, Martin Smith, Adam Stonier, 2008 .

Dynamic Simulation Framework for Design of Lean Biopharmaceutical Manufacturing Operations

Suzanne S. Farid, Martin Smith, Adam Stonier, 2009 .

Dynamic scheduling of multi-product continuous biopharmaceutical facilities: A hyper-heuristic framework

Jürgen Branke, Suzanne S. Farid, Richard Allmendinger, 2019, Comput. Chem. Eng..

Multiobjective evolutionary optimization in antibody purification process design

Suzanne S. Farid, Ana S. Simaria, Richard Allmendinger, 2013 .

Application of quality by design principles to the development and technology transfer of a major process improvement for the manufacture of a recombinant protein

Suzanne S. Farid, Kevin Buckley, Enda Moran, 2011, Biotechnology progress.

Biopharmaceutical capacity planning for batch and semi-continuous bioprocesses under various strategic criteria

Lazaros G. Papageorgiou, Suzanne S. Farid, Thomas Daszkowski, 2015 .

Structured decisional-support tool for rapid bioprocess modelling.

Suzanne S. Farid, Nigel J. Titchener-Hooker, John Washbrook, 2003 .

Large Scale Suspension Culture of Mammalian Cells

Suzanne S. Farid, John Birch, Andrew J. Racher, 2014 .

Evaluating and Visualizing the Cost‐Effectiveness and Robustness of Biopharmaceutical Manufacturing Strategies

Suzanne S. Farid, 2012 .

Decision support tools for cost-effective bioprocess design in the cell therapy sector

Suzanne S. Farid, Ronald W. Fedechko, Michael J. Jenkins, 2017 .

Cost-effectiveness of single-use technologies for commercial cell therapy manufacture

Suzanne S. Farid, Ana S. Simaria, Sally Hassan, 2013 .

Designing multi-product biopharmaceutical facilities using evolutionary algorithms

Ying Gao, Suzanne S. Farid, Ana S. Simaria, 2011 .

Dynamic Optimisation of the Drug Development Pathway

Suzanne S. Farid, Nigel J. Titchener-Hooker, Anuradha Rajapakse, 2003 .

A Multiobjective Evolutionary Optimization Framework for Protein Purification Process Design

Suzanne S. Farid, Richard Allmendinger, 2014, PPSN.

Gene therapy process change evaluation framework: Transient transfection and stable producer cell line comparison

Suzanne S. Farid, Bo Kara, Ruxandra-Maria Comisel, 2021, Biochemical Engineering Journal.

Integrated Optimization of Upstream and Downstream Processing in Biopharmaceutical Manufacturing under Uncertainty: A Chance Constrained Programming Approach

Lazaros G. Papageorgiou, Suzanne S. Farid, Songsong Liu, 2016 .

Predicting performance of constant flow depth filtration using constant pressure filtration data

Suzanne S. Farid, Stephen Goldrick, Adrian Joseph, 2017 .

Bioprocesses for Cell Therapies

Suzanne S. Farid, Michael J. Jenkins, 2018 .

Stochastic Combinatorial Optimization Approach to Biopharmaceutical Portfolio Management

Suzanne S. Farid, Edmund D. George, 2008 .

A scale‐down mimic for mapping the process performance of centrifugation, depth and sterile filtration

Suzanne S. Farid, Stephen Goldrick, Adrian Joseph, 2016, Biotechnology and bioengineering.

On-Line Control of Glucose Concentration in High-Yielding Mammalian Cell Cultures Enabled Through Oxygen Transfer Rate Measurements.

Suzanne S. Farid, Stephen Goldrick, Marcel Kuiper, 2018, Biotechnology journal.

Economic Drivers and Trade-Offs in Antibody Purification Processes : The future of therapeutic MAbs lies in the development of economically feasible downstream processes

Suzanne S. Farid, S. Farid, 2008 .